Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-08 Purchase |
2022-07-13 9:27 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner |
19,270,476 | $2.2 | $42,395,047 | 76,616,270 (Indirect Direct) |
View |
| 2022-03-31 Purchase |
2022-04-01 4:52 pm |
Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner |
5,385,208 | $5 | $26,926,040 | 44,441,416 (Indirect Direct) |
View |
| 2022-02-09 Purchase |
2022-02-11 6:56 pm |
Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner |
3,614,792 | $5 | $18,073,960 | 36,363,604 (Indirect Direct) |
View |
| 2021-10-29 Purchase |
2021-11-01 2:20 pm |
Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner |
1,212,122 | $3.3 | $4,000,003 | 16,076,769 (Indirect Direct) |
View |
| 2021-06-11 Purchase |
2021-06-11 5:39 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner |
6,268,975 | $2 | $12,537,950 | 57,345,794 (Indirect Direct) |
View |
| 2021-05-03 Purchase |
2021-05-20 2:39 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner |
3,731,025 | $2 | $7,462,050 | 44,807,844 (Indirect Direct) |
View |
| 2021-03-17 Purchase |
2021-03-17 5:16 pm |
Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner |
4,285,935 | $3.25 | $13,929,289 | 29,729,294 (Indirect Direct) |
View |
| 2021-01-26 Purchase |
2021-01-28 1:43 pm |
Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner |
1,867,912 | $3.25 | $6,070,714 | 21,157,424 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-18 Other |
2022-02-23 1:05 pm |
N/A 2022-08-18 |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner |
0 | $0 | 57,345,794 (Indirect) |
View |